AngioDynamics, Inc.

ANGO Healthcare Medical Instruments & Supplies

AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025. In the quarter to August 2026, revenue grew 6.87%, EPS grew 35.0% and free cash flow grew 5.62%, each against the same quarter a year earlier.

11.25 0.33 −2.85%
Market cap
$487.0M
P/E
0.0×
Fwd P/E
−20.7×
Dividend yield
—
F-score
5/9
Altman Z
1.63
Beneish M
−3.08
Dividend safety
n/a
Aug '26 May '26 Feb '26 Nov '25 Older periods
Piotroski F-Score
6 5 6 6

+8 more TTM periods

ROE
(19.21%) (20.77%) (17.47%) (15.26%)
ROA
(12.98%) (13.43%) (11.50%) (9.87%)
ROIC
(17.58%) (21.34%) (16.38%) (15.10%)
Return on Tangible Assets
(29.66%) (31.74%) (26.46%) (23.11%)
Average Days of Receivables
50.37 55.09 53.00 52.78
Free Cash Flow per Share
0.03 0.01 0.04 (0.22)
Free Cash Flow
1.44 0.51 1.50 (9.33)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Oct 2026